bioRxiv (Cold Spring Harbor Laboratory),
Год журнала:
2024,
Номер
unknown
Опубликована: Апрель 11, 2024
Abstract
The
severe
acute
respiratory
syndrome
coronavirus
type
2
(SARS-CoV-2),
causing
human
disease
2019
(COVID-19),
not
only
affects
the
tract,
but
also
impacts
other
organs
including
brain.
A
considerable
number
of
COVID-19
patients
develop
neuropsychiatric
symptoms
that
may
linger
for
weeks
and
months
contribute
to
“long-COVID”.
While
neurological
are
well
described,
cellular
mechanisms
neurologic
disorders
attributed
infection
still
enigmatic.
Here,
we
studied
effect
an
with
SARS-CoV-2
on
structure
expression
marker
proteins
astrocytes
microglial
cells
in
frontal
cortex
who
died
from
comparison
non-COVID-19
controls.
Most
had
retracted
processes
rounded
enlarged
cell
bodies
both
gray
white
matter,
as
visualized
by
anti-Iba1
staining
confocal
fluorescence
microscopy.
In
addition,
matter
were
frequently
labeled
intense
anti-GFAP
staining,
whereas
controls,
most
expressed
little
GFAP.
striking
difference
between
controls
was
found
anti-aquaporin-4
(AQP4)
staining.
patients,
a
large
showed
increase
AQP4.
AQP4
polarity
lost
covered
entire
cell,
body
all
processes,
while
immunostaining
mainly
detected
endfeet
around
blood
vessels
did
visualize
body.
summary,
our
data
suggest
neuroinflammation
upon
microgliosis
astrogliosis,
loss
polarity.
Research Square (Research Square),
Год журнала:
2024,
Номер
unknown
Опубликована: Янв. 5, 2024
Abstract
The
spectrum,
pathophysiology,
and
recovery
trajectory
of
persistent
post-COVID-19
cognitive
deficits
are
unknown,
limiting
our
ability
to
develop
prevention
treatment
strategies.
We
report
the
one-year
cognitive,
serum
biomarker,
neuroimaging
findings
from
a
prospective,
national
longitudinal
study
cognition
in
351
COVID-19
patients
who
had
required
hospitalisation,
compared
2,927
normative
matched
controls.
Cognitive
were
global
associated
with
elevated
brain
injury
markers
reduced
anterior
cingulate
cortex
volume
one
year
after
admission.
severity
initial
infective
insult,
post-acute
psychiatric
symptoms,
history
encephalopathy
greatest
deficits.
There
was
strong
concordance
between
subjective
objective
Treatment
corticosteroids
during
acute
phase
appeared
protective
against
Together,
these
support
hypothesis
that
moderate
severe
is
immune-mediated,
should
guide
development
therapeutic
Severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
recently
caused
a
global
pandemic,
resulting
in
more
than
702
million
people
being
infected
and
over
6.9
deaths.
Patients
with
disease
(COVID-19)
may
suffer
from
diarrhea,
sleep
disorders,
depression,
even
cognitive
impairment,
which
is
associated
long
COVID
during
recovery.
However,
there
remains
no
consensus
on
effective
treatment
methods.
Studies
have
found
that
patients
COVID-19
alterations
microbiota
their
metabolites,
particularly
the
gut,
be
involved
regulation
of
immune
responses.
Consumption
probiotics
alleviate
discomfort
by
inflammation
oxidative
stress.
pathophysiological
process
underlying
alleviation
COVID-19-related
symptoms
complications
targeting
unclear.
In
current
study,
we
summarize
latest
research
evidence
together
SARS-CoV-2
vaccine
use,
focus
relationship
between
use.
This
work
provides
probiotic-based
interventions
improve
regulating
gut
systemic
immunity.
Probiotics
also
used
as
adjuvants
to
efficacy.
Scientific Reports,
Год журнала:
2024,
Номер
14(1)
Опубликована: Авг. 17, 2024
Patients
recovering
from
COVID-19
commonly
exhibit
cognitive
and
brain
alterations,
yet
the
specific
neuropathological
mechanisms
risk
factors
underlying
these
alterations
remain
elusive.
Given
significant
global
incidence
of
COVID-19,
identifying
that
can
distinguish
individuals
at
developing
is
crucial
for
prioritizing
follow-up
care.
Here,
we
report
findings
a
sample
patients
consisting
73
adults
with
mild
to
moderate
SARS-CoV-2
infection
without
signs
respiratory
failure
27
infections
attributed
other
agents
no
history
COVID-19.
The
participants
underwent
screening,
decision-making
task,
MRI
evaluations.
We
assessed
presence
anosmia
requirement
hospitalization.
Groups
did
not
differ
in
age
or
performance.
who
presented
exhibited
more
impulsive
alternative
changes
after
shift
probabilities
(r
=
−
0.26,
p
0.001),
while
required
hospitalization
showed
perseverative
choices
0.25,
0.003).
Anosmia
correlated
measures,
including
decreased
functional
activity
during
thinning
cortical
thickness
parietal
regions,
loss
white
matter
integrity.
Hence,
could
be
factor
considered
when
at-risk
populations
follow-up.
Clinical Microbiology Reviews,
Год журнала:
2024,
Номер
37(4)
Опубликована: Сен. 18, 2024
SUMMARYSARS-CoV-2
can
not
only
cause
respiratory
symptoms
but
also
lead
to
neurological
complications.
Research
has
shown
that
more
than
30%
of
SARS-CoV-2
patients
present
neurologic
during
COVID-19
(A.
Pezzini
and
A.
Padovani,
Nat
Rev
Neurol
16:636-644,
2020,
https://doi.org/10.1038/s41582-020-0398-3).
Increasing
evidence
suggests
invade
both
the
central
nervous
system
(CNS)
(M.S.
Xydakis,
M.W.
Albers,
E.H.
Holbrook,
et
al.
Lancet
20:
753-761,
2021
https://doi.org/10.1016/S1474-4422(21)00182-4
)
peripheral
(PNS)
(M.N.
Soares,
M.
Eggelbusch,
E.
Naddaf,
J
Cachexia
Sarcopenia
Muscle
13:11-22,
2022,
https://doi.org/10.1002/jcsm.12896),
resulting
in
a
variety
disorders.
This
review
summarized
CNS
complications
caused
by
infection,
including
encephalopathy,
neurodegenerative
diseases,
delirium.
Additionally,
some
PNS
disorders
such
as
skeletal
muscle
damage
inflammation,
anosmia,
smell
or
taste
impairment,
myasthenia
gravis,
Guillain-Barré
syndrome,
ICU-acquired
weakness,
post-acute
sequelae
were
described.
Furthermore,
mechanisms
underlying
SARS-CoV-2-induced
discussed,
entering
brain
through
retrograde
neuronal
hematogenous
routes,
disrupting
normal
function
cytokine
storms,
inducing
cerebral
ischemia
hypoxia,
thus
leading
Moreover,
an
overview
long-COVID-19
is
provided,
along
with
recommendations
for
care
therapeutic
approaches
experiencing
Biomedical Journal,
Год журнала:
2024,
Номер
unknown, С. 100766 - 100766
Опубликована: Июль 1, 2024
Severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
interacts
between
the
host
and
virus
govern
induction,
resulting
in
multiorgan
impacts.
Its
pathophysiology
involves
followings:
1)
angiotensin-converting
enzyme
(ACE2)
Toll-like
receptor
(TLR)
pathways:
2)
neuropilin
(NRP)
pathway:
3)
spike
protein
pathway.
Therefore,
it
is
necessary
to
block
pathological
course
with
modulating
innate
lymphoid
cells
against
diverse
corona
variants
future.
Viruses,
Год журнала:
2025,
Номер
17(1), С. 98 - 98
Опубликована: Янв. 14, 2025
Post-acute
sequelae
of
COVID-19
(PASC)
are
a
diverse
set
symptoms
and
syndromes
driven
by
dysfunction
multiple
organ
systems
that
can
persist
for
years
negatively
impact
the
quality
life
millions
individuals.
We
currently
lack
specific
therapeutics
patients
with
PASC,
due
in
part
to
an
incomplete
understanding
its
pathogenesis,
especially
non-pulmonary
sequelae.
Here,
we
discuss
three
animal
models
have
been
utilized
investigate
PASC:
non-human
primates
(NHPs),
hamsters,
mice.
focus
on
neurological,
gastrointestinal,
cardiovascular
PASC
highlight
advances
mechanistic
insight
made
using
these
models,
as
well
discussing
warrant
continued
intensive
research.
Forensic Sciences,
Год журнала:
2025,
Номер
5(1), С. 8 - 8
Опубликована: Фев. 12, 2025
Background:
Hospital
autopsies,
once
considered
fundamental
to
evidence-based
medicine,
have
declined
in
many
Western
countries
due
legislative
changes,
faith-based
objections,
and
inadequate
funding
public
healthcare.
However,
the
COVID-19
pandemic
has
revitalized
interest
their
importance
for
determining
cause
of
death
generating
health
statistics.
This
study
analyzes
factors
contributing
this
decline,
with
a
focus
on
Italian
context
new
medicolegal
perspectives
arising
post-pandemic
era.
Methods:
The
research
was
conducted
through
an
analysis
91
relevant
scientific
sources,
including
government
documents,
policy
briefs,
academic
studies.
Legislative
regulatory
influencing
reduction
hospital
autopsies
were
examined,
along
technological
that
emerged
following
pandemic.
Special
attention
given
pandemic’s
impact
autopsy
practices.
Results:
revealed
perceived
“low
value”
often
stems
from
advancements,
which
led
view
these
procedures
as
redundant.
post-COVID-19
era,
there
been
renewed
awareness
value
significant
implications
statistics
evolution
forensic
medicine.
Conclusions:
highlighted
vital
role
delivering
accurate
medical
information,
prompting
Moving
forward,
will
need
balance
innovations
traditional
practices,
paving
way
medicine
data
management.
Current Opinion in Infectious Diseases,
Год журнала:
2025,
Номер
unknown
Опубликована: Апрель 1, 2025
Purpose
of
review
Since
its
emergence
in
2020,
the
COVID-19
pandemic
has
created
a
global
surge
survivors
experiencing
neurologic
effects
from
SARS-CoV-2
infection.
This
aims
to
provide
an
updated
synthesis
acute
and
chronic
neurological
manifestations
COVID-19,
outline
current
therapeutic
strategies
for
these
conditions.
Recent
findings
Epidemiological
studies
have
shown
that
patients
with
symptoms
during
infection
tend
poorer
hospital
functional
outcomes.
While
risk
adverse
including
cognitive
dysfunction,
headache,
autonomic
fatigue
are
thought
be
greatest
following
original
strain
alpha
variant,
they
remain
prevalent
after
subsequent
less
virulent
strains
as
well.
Some
recent
work
also
found
link
between
structural
brain
changes.
However,
ongoing
trials
show
promising
results
pharmacologic
nonpharmacologic
treatments
targeting
postacute
sequelae
COVID-19.
Summary
Lingering
still
pose
considerable
individual,
healthcare
system,
socioeconomic
repercussions.
Both
preventive
multimodal
treatment
approaches
necessary
address
Further
research
is
required
assess
lasting
impacts
on
nervous
particularly
potential
contribution
development
neurodegenerative
diseases.